NCT04593797

Brief Summary

Rationale: Diligent fluid management is instrumental to improve postoperative outcome, cost and quality of care. Objective: To determine the accuracy of brachial, femoral and carotid blood flow measurement with ultrasound compared to intermittent transpulmonary thermodilution cardiac output measurement, invasive and non-invasive pulse-contour analysis. Study design: Observational study - Prospective clinical non-intervention measurement study. Study population: Adult ASA 1-2 patients, scheduled for open upper GI surgery Intervention (if applicable): Not applicable. We will perform non-invasive ultrasound measurements of the femoral, carotid and brachial blood flow right before induction and under anaesthesia. Main study parameters/endpoints: Femoral, carotid and brachial blood flow determined by ultrasound and blood flow variation and the accuracy compared to transpulmonary thermodilution cardiac output, stroke volume variation, and pulse-contour analysis derived cardiac output (invasive or non-invasive) at the following time points during surgery; (limited for femoral site as it cannot be measured during surgery): (1) before induction of anaesthesia, (2) after induction, (3) 15 minutes after start of surgery, (4) before and (5) after (1-2 minutes) a fluid bolus, (6) before and (7) after start of vasopressors, (8) before and (9) after Trendelenburg position and (10) after surgery before end of anaesthesia (figure 1). A fluid bolus will be performed as part of standard care (goal-directed fluid therapy). The vasopressor and Trendelenburg position time points are optional measurements. We will also measure (continuous) invasive femoral blood pressure (SBP, DBP, MAP), non-invasive blood pressure, SVV, central venous pressure (when available), heart rate, SpO2, PFI, etCO2.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 19, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 9, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 9, 2019

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 29, 2020

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 20, 2020

Completed
Last Updated

October 20, 2020

Status Verified

October 1, 2020

Enrollment Period

9 months

First QC Date

September 29, 2020

Last Update Submit

October 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiac output

    blood flow determined by ultrasound and the accuracy compared to transpulmonary thermodilution calibrated continuous cardiac output

    baseline

Secondary Outcomes (1)

  • Cardiac output change

    change from baseline cardiac output 1 minute after intervention (fluid challenge, vasopressor administration, or Trendelenburg)

Study Arms (1)

Patients undergoing major upper abdominal surgery

major open upper abdominal surgery eg pancreatic, liver surgery

Diagnostic Test: carotid blood flow measurement with ultrasound

Interventions

carotid blood flow measurement with ultrasound vs transpulmonary thermodilution calibrated continuous cardiac output measurements

Also known as: transpulmonary thermodilution calibrated continuous cardiac output measurements
Patients undergoing major upper abdominal surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients, scheduled for open upper GI surgery with a American Society of Anaesthesiologist score of 1 to 2

You may qualify if:

  • Elective open GI surgery
  • Invasive arterial blood pressure monitoring
  • Informed consent

You may not qualify if:

  • Significant stenosis \> 30% or abnormal anatomy of aortic, femoral, carotid or brachial artery
  • Cerebrovascular accident
  • Atrial fibrillation
  • COPD stage 3-4
  • Lobectomy / pneumectomy
  • Active pneumonia
  • Cardiac failure
  • Severe heart valve regurgitation or stenosis
  • Not able to measure brachial or carotid artery blood flow during surgery
  • Contra-indications for femoral arterial catheter placement (e.g., vascular graft)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Academisch Medisch Centrum - Universiteit van Amsterdam

Amsterdam, Netherlands

Location

MeSH Terms

Conditions

Cardiac Output, LowCardiac Output, High

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • A.P. Vlaar, MD, PhD

    Amsterdam UMC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 29, 2020

First Posted

October 20, 2020

Study Start

April 19, 2018

Primary Completion

January 9, 2019

Study Completion

January 9, 2019

Last Updated

October 20, 2020

Record last verified: 2020-10

Locations